Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IBO
IBO logo

IBO Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Impact Biomedical Inc (IBO) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.480
1 Day change
1.06%
52 Week Range
1.950
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

IBO is not a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is showing a weak technical setup, no supportive news or analyst momentum, no meaningful institutional or insider buying, and no proprietary buy signal. Based on the available data, the direct opinion is to avoid buying now.

Technical Analysis

The current trend is bearish. MACD histogram is negative and still contracting, RSI_6 at 39.54 shows weak momentum without a clear reversal signal, and the moving averages are bearish with SMA_200 > SMA_20 > SMA_5. Price at 0.472 is below the pivot level of 0.502 and only slightly above support at 0.454, which leaves limited upside unless momentum improves. The stock trend model also points to weakness, with estimated negative performance over the next day, week, and month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is not providing a useful bullish signal. The reported put-call ratios are 0.0, but the data set is incomplete with missing open interest and volume details, so sentiment cannot be confirmed as supportive. Historical volatility is very high at 214.69, which reflects a speculative profile rather than a stable long-term setup.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
1

Positive Catalysts

  • No recent news catalysts were reported. There is no recent congress trading activity, no notable insider buying, and hedge funds are neutral. Proprietary signals are also absent: AI Stock Picker shows no signal and SwingMax shows no recent signal.

Neutral/Negative Catalysts

  • No news in the recent week means no visible event-driven catalyst. Technical momentum is weak, the trend model is negative, hedge funds and insiders are neutral, and there is no recent congress trading data. The stock is also trading in a low-price, high-volatility profile without supporting fundamental data.

Financial Performance

No usable financial snapshot was available, so latest-quarter growth cannot be assessed. Because the latest quarter season is not provided, there is no evidence here to support a fundamental buy case.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible Wall Street upgrade momentum. Based on the available information, the pro view is weak because there are no analyst-driven bullish revisions, while the con view dominates due to the lack of catalysts, weak technicals, and absent institutional support.

Wall Street analysts forecast IBO stock price to rise
Analyst Rating
0
Wall Street analysts forecast IBO stock price to rise
Buy
Hold
Sell
0
Current: 0.472
sliders
Low
0
Averages
0
High
0
0
Current: 0.472
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch